Connect with us

GenAI Monetization Will Take Time: AlTi Tiedemann

Nancy Curtin, chief investment officer at AlTi Tiedemann Global, joins Caroline Hyde and Ed Ludlow to weigh in on Tesla’s quarterly delivery numbers as well as to discuss why she thinks monetization of hyperscalers’ spend in AI will take time. She speaks on “Bloomberg Technology.” ——– Like this video? Subscribe to Bloomberg Technology on YouTube:…

Published

on

Nancy Curtin, chief investment officer at AlTi Tiedemann Global, joins Caroline Hyde and Ed Ludlow to weigh in on Tesla’s quarterly delivery numbers as well as to discuss why she thinks monetization of hyperscalers’ spend in AI will take time. She speaks on “Bloomberg Technology.”
——–
Like this video? Subscribe to Bloomberg Technology on YouTube:

 
Watch the latest full episodes of “Bloomberg Technology” with Caroline Hyde and Ed Ludlow here:

 
Get the latest in tech from Silicon Valley and around the world here:

Connect with us on…
X:
Facebook:
Instagram:
 
Follow Ed Ludlow on X here:
Follow Caroline Hyde on X here:
 
Listen to the daily Bloomberg Technology podcast here:

 
More from Bloomberg Business
Connect with us on…
X:
Facebook:
Instagram:
LinkedIn:
TikTok:

Continue Reading
Advertisement
1 Comment

1 Comment

  1. @shoopddawhooped

    October 2, 2024 at 6:50 pm

    AlTi Tiedemann Global $68 billion in combined assets
    ALTI (NASDAQ) $3.57 -0.07 (-1.92%) Oct 2
    Headquarters: United States Subsidiaries: TFI Partners LLC, SIR Trustee Limited · Founded: 2022

Leave a Reply

Your email address will not be published. Required fields are marked *

Science & Technology

Intero Biosystems Wins Startup Battlefield for its Lab-Grown Digestive Systems

Congrats to Intero Biosystems, this year’s Startup Battlefield 200 victor! They’re developing lab-grown tissue that mimics our digestive system, to study how drugs and compounds effect our bodies…before they effect our bodies.

Published

on

Congrats to Intero Biosystems, this year’s Startup Battlefield 200 victor!

They’re developing lab-grown tissue that mimics our digestive system, to study how drugs and compounds effect our bodies…before they effect our bodies.

Continue Reading

Science & Technology

Bluesky’s Leadership Thinks Social Can Still Start Over | Disrupt 2026

Can social media enter a new era? With a new leadership team at the helm, Bluesky is betting that openness, user choice, and new technology can reshape how online communities are built. CEO Toni Schneider and COO Rose Wang discuss the future of social media, competing with established platforms, and what it takes to build…

Published

on

Can social media enter a new era? With a new leadership team at the helm, Bluesky is betting that openness, user choice, and new technology can reshape how online communities are built. CEO Toni Schneider and COO Rose Wang discuss the future of social media, competing with established platforms, and what it takes to build the next generation of consumer technology.

#TechCrunchDisrupt2026

Follow us across…

Read more:

Continue Reading

Science & Technology

Why Most Deep Tech Startups Stall Between Prototype and Production | Disrupt 2026

Founders may have the right team and tech and still miss what it takes to manufacture and scale. Bedrock Robotics’ Kevin Peterson and Foxglove’s Adrian Macneil share what they’ve learned about crossing that gap. #TechCrunchDisrupt2026 Follow us across… Read more:

Published

on

Founders may have the right team and tech and still miss what it takes to manufacture and scale. Bedrock Robotics’ Kevin Peterson and Foxglove’s Adrian Macneil share what they’ve learned about crossing that gap.

#TechCrunchDisrupt2026

Follow us across…

Read more:

Continue Reading

Trending